Overview

Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension

Status:
Completed

Trial end date:
2007-05-01

Target enrollment:

Participant gender:

Summary

This study is conducted to investigate the effect of the oral renin inhibitor SPP635 on blood pressure in patients with mild to moderate hypertension.

Phase:

Phase 2

Details

Lead Sponsor:

Speedel Pharma Ltd.